mhurhangee/ep-ind-claims huggingface dataset:
An electronic cigarette, comprising: a power supply; and an atomizer, the atomizer being connected with the power supply via a detachable connecting structure, the power supply having a connecting end connecting with the atomizer, the power supply comprising an electromagnetic induction coil at the connecting end, the atomizer comprising a housing, a liquid chamber arranged in the housing, and a metallic element, the metallic element being capable of generating heat in an alternating magnetic field, the liquid chamber defining an opening facing the power supply, the atomizer further comprising a liquid storing element arranged in the opening, the liquid storing element being capable of storing tobacco liquid, and preventing tobacco liquid in the liquid chamber from flowing out, the metallic element abutting against the liquid storing element, the metallic element being configured for heating the tobacco liquid absorbed in the liquid storing element to form aerosol, whereby the detachable connecting structure between the power supply and the atomizer is a screw thread structure, a snap-fit structure, or a magnetic attraction structure. a power supply; and an atomizer, the atomizer being connected with the power supply via a detachable connecting structure, the power supply having a connecting end connecting with the atomizer, the power supply comprising an electromagnetic induction coil at the connecting end, the atomizer comprising a housing, a liquid chamber arranged in the housing, and a metallic element, the metallic element being capable of generating heat in an alternating magnetic field, the liquid chamber defining an opening facing the power supply, the atomizer further comprising a liquid storing element arranged in the opening, the liquid storing element being capable of storing tobacco liquid, and preventing tobacco liquid in the liquid chamber from flowing out, the metallic element abutting against the liquid storing element, the metallic element being configured for heating the tobacco liquid absorbed in the liquid storing element to form aerosol, whereby the detachable connecting structure between the power supply and the atomizer is a screw thread structure, a snap-fit structure, or a magnetic attraction structure.
A multi-column for isolating exosomes, the multi-column comprising: porous beads (a) having a pore size of 20 nanometers (nm) to 100 nm; porous beads (b) stacked on the porous beads (a) and having a pore size of 20 nm or less; and a separation membrane disposed between the porous beads (a) and (b), wherein the porous beads (a) isolate exosomes from lipoproteins in a biological sample, and the porous beads (b) isolate the exosomes from water-soluble proteins in the biological sample. porous beads (a) having a pore size of 20 nanometers (nm) to 100 nm; porous beads (b) stacked on the porous beads (a) and having a pore size of 20 nm or less; and a separation membrane disposed between the porous beads (a) and (b), wherein the porous beads (a) isolate exosomes from lipoproteins in a biological sample, and the porous beads (b) isolate the exosomes from water-soluble proteins in the biological sample.
Control device for an internal combustion engine comprising an intake channel, an exhaust gas recirculation channel opening into the intake channel, a housing in which the intake channel and at least one mouth of the exhaust gas recirculation channel are formed, a shaft serving as a rotary axis, which is disposed in the housing upstream of the mouth of the exhaust gas recirculation channel and is arranged outside the flow cross section of a first channel section of the intake channel, a control body attached eccentrically to the shaft, a first channel section in a first housing part, at the downstream end of which a first valve seat is formed, against which the control body abuts in a first end position, and the outer circumference of which is smaller than the outer circumference of a second channel section adjoining in the downstream direction and a second valve seat on the second channel section, against which the control body abuts in a second end position, in which the control body closes the exhaust gas recirculation channel, characterized in that the shape of a surface of the control body facing the interior of the intake channel in the second end position corresponds, in a cross section perpendicular to the central axis of the first housing part, to an inner wall surface adjacent to the control body of the first channel section over an angle of at least 90°.
A combination oxygenator and arterial filter device for treating blood in an extracorporeal blood circuit, the device comprising: a housing; a core maintained within the housing and defining a central longitudinal axis; and a fiber bundle disposed within the housing, the fiber bundle formed by a plurality of hollow microporous fibers continuously helically wound about the core to generate a plurality of layers, each layer being composed of level wound fibers and each successive layer being radially outward of an immediately preceding layer relative to the central longitudinal axis; wherein the layers of the fiber bundle combine to define an oxygenator region and a depth filter region, the depth filter region being radially outward of the oxygenator region; and characterized in that a minimum gap spacing between axially adjacent fibers of the oxygenator region layers is greater than a minimum gap spacing between axially adjacent fibers of the depth filter region layers, wherein the minimum gap spacing between axially adjacent fibers of the oxygenator region layers is in the range of 75-150 microns, and the minimum gap spacing between axially adjacent fibers of the depth filter region layers is in the range of 40-75 microns. a housing; a core maintained within the housing and defining a central longitudinal axis; and a fiber bundle disposed within the housing, the fiber bundle formed by a plurality of hollow microporous fibers continuously helically wound about the core to generate a plurality of layers, each layer being composed of level wound fibers and each successive layer being radially outward of an immediately preceding layer relative to the central longitudinal axis; wherein the layers of the fiber bundle combine to define an oxygenator region and a depth filter region, the depth filter region being radially outward of the oxygenator region; and characterized in that a minimum gap spacing between axially adjacent fibers of the oxygenator region layers is greater than a minimum gap spacing between axially adjacent fibers of the depth filter region layers, wherein the minimum gap spacing between axially adjacent fibers of the oxygenator region layers is in the range of 75-150 microns, and the minimum gap spacing between axially adjacent fibers of the depth filter region layers is in the range of 40-75 microns. a minimum gap spacing between axially adjacent fibers of the oxygenator region layers is greater than a minimum gap spacing between axially adjacent fibers of the depth filter region layers, wherein the minimum gap spacing between axially adjacent fibers of the oxygenator region layers is in the range of 75-150 microns, and the minimum gap spacing between axially adjacent fibers of the depth filter region layers is in the range of 40-75 microns.
A method of operating a transmitter (105, 115) for use with a base station, comprising: generating a primary synchronization signal PSS, the PSS associated with a cell identification, ID, of a cell, wherein a symbol of the PSS carries three hypotheses of the cell ID; generating a secondary synchronization signal, SSS, the SSS associated with a cell identity group for the cell, the SSS derived from two sequences, wherein each of the two sequences is selected from a same set of N sequences and indexed by an index pair (S 1, S 2) with S 1 and S 2 being within a range of zero to N-1, wherein the index pair S 1, S 2 is contained in a mapped set of index pairs corresponding to the same set of N sequences and wherein each of the two sequences is used as an even sequence in a first segment of the SSS and as an odd sequence in a second segment of the SSS; and transmitting the primary and secondary synchronization signals (205, 210). generating a primary synchronization signal PSS, the PSS associated with a cell identification, ID, of a cell, wherein a symbol of the PSS carries three hypotheses of the cell ID; generating a secondary synchronization signal, SSS, the SSS associated with a cell identity group for the cell, the SSS derived from two sequences, wherein each of the two sequences is selected from a same set of N sequences and indexed by an index pair (S 1, S 2) with S 1 and S 2 being within a range of zero to N-1, wherein the index pair S 1, S 2 is contained in a mapped set of index pairs corresponding to the same set of N sequences and wherein each of the two sequences is used as an even sequence in a first segment of the SSS and as an odd sequence in a second segment of the SSS; and transmitting the primary and secondary synchronization signals (205, 210).
Device intended for ensuring the connection of straps, objects or parts of garments or accessories characterised in that it comprises two strictly identical and complementary parts, so that they may be combined to form a coherent assembly, to do this, these parts have a main body provided with two or three parallel lobes which are flat and curved portions that fit into each other, the device is characterised in that these lobes are provided on the one hand with circular movable mechanisms that bend in order to lock the device, for their male portion, and on the other hand with circular movable mechanisms that bend and act as push buttons to release the device, for their female portion, the architecture and mode of connection of the parts make it possible to assemble not just two parts, but also three, four, five parts or more, simultaneously allowing to fulfil particular functionalities or deal with specific strap shapes.
A system for measuring modulation of G protein activation in a Gα protein subunit family-selective manner, said system comprising a cell expressing: (i) a first component comprising a Gα subunit interacting polypeptide (GASIP) tagged with a bioluminescent donor molecule or a fluorescent acceptor molecule; wherein said GASIP comprises the G protein-binding domain of: Rap1GAP, a Regulator of G-protein signaling protein, P63RhoGEF, PDZRhoGEF, or P115RhoGEF; (ii) a second component comprising a plasma membrane -targeting moiety comprising (a) a palmitoylation, myristoylation, and/or prenylation signal sequence and/or (b) a polybasic sequence, an endosomal-targeting moiety or a Golgi-targeting moiety tagged with a bioluminescent donor molecule or a fluorescent acceptor molecule; wherein if said GASIP is tagged with said fluorescent acceptor molecule, said PM-targeting moiety, endosomal-targeting moiety or Golgi-targeting moiety is tagged with said bioluminescent donor molecule, and if said GASIP is tagged with said bioluminescent donor molecule, said PM-targeting moiety, endosomal-targeting moiety or Golgi-targeting moiety is tagged with said fluorescent acceptor molecule; (iii) a third component that is a cell surface receptor that signals through said G protein, wherein said receptor is a GPCR, an RTK or an integrin receptor; and wherein there is no direct protein-protein interaction between (i) the PM-targeting moiety, endosomal-targeting moiety or Golgi-targeting moiety and (ii) the GASIP. (i) a first component comprising a Gα subunit interacting polypeptide (GASIP) tagged with a bioluminescent donor molecule or a fluorescent acceptor molecule; wherein said GASIP comprises the G protein-binding domain of: Rap1GAP, a Regulator of G-protein signaling protein, P63RhoGEF, PDZRhoGEF, or P115RhoGEF; (ii) a second component comprising a plasma membrane -targeting moiety comprising (a) a palmitoylation, myristoylation, and/or prenylation signal sequence and/or (b) a polybasic sequence, an endosomal-targeting moiety or a Golgi-targeting moiety tagged with a bioluminescent donor molecule or a fluorescent acceptor molecule; wherein if said GASIP is tagged with said fluorescent acceptor molecule, said PM-targeting moiety, endosomal-targeting moiety or Golgi-targeting moiety is tagged with said bioluminescent donor molecule, and if said GASIP is tagged with said bioluminescent donor molecule, said PM-targeting moiety, endosomal-targeting moiety or Golgi-targeting moiety is tagged with said fluorescent acceptor molecule; (iii) a third component that is a cell surface receptor that signals through said G protein, wherein said receptor is a GPCR, an RTK or an integrin receptor;
A method for treating biological tissue, comprising the steps of a) impregnating said biological tissue with a trehalose solution; b) drying said biological tissue; and c) sterilizing said biological tissue, wherein said sterilization step is performed using ethylene oxide gas or hydrogen-peroxide low-temperature plasma, wherein the concentration of said trehalose solution is 20 wt% to 35 wt%, and wherein the biological tissue is bovine pericardium or bovine tendon. a) impregnating said biological tissue with a trehalose solution; b) drying said biological tissue; and c) sterilizing said biological tissue,
A method of starting a single-phase induction motor, the motor being provided with a rotor and a stator, the stator being provided with a main winding and a start winding, the main winding and the start winding of the single-phase induction motor being energized by means of an alternating voltage source, the starting winding being selectively activated and deactivated by a starting device, the method comprising the steps of: i) energizing the start winding and continuously estimating an operating rotation (R 1) of the single-phase induction motor throughout its operation through the phase shift between at least two electrical quantities; ii) measuring a first phase shift level (D 1) between the at least two electrical quantities of the motor along a first stability stage (E 1); iii) monitoring the variation of the first phase shift level (D 1) according to the increase of the operating rotation (R 1) of the single-phase induction motor along the first stability stage (E 1); iv) detecting an inflection stage (E inf) from the first phase shift level (D 1) to a second phase shift level (D 2), when the operating rotation (R 1) of the single-phase induction motor is close to a regime rotation (R 2); v) measuring the second phase shift level (D 2) between the at least two electrical quantities of the motor along a second stability stage (E 2), after the inflection stage (E inf) of the first phase shift level (D 1); and vi) de-energizing the start winding when the operating rotation (R 1) reaches the regime rotation (R 2). i) energizing the start winding and continuously estimating an operating rotation (R 1) of the single-phase induction motor throughout its operation through the phase shift between at least two electrical quantities; ii) measuring a first phase shift level (D 1) between the at least two electrical quantities of the motor along a first stability stage (E 1); iii) monitoring the variation of the first phase shift level (D 1) according to the increase of the operating rotation (R 1) of the single-phase induction motor along the first stability stage (E 1); iv) detecting an inflection stage (E inf) from the first phase shift level (D 1) to a second phase shift level (D 2), when the operating rotation (R 1) of the single-phase induction motor is close to a regime rotation (R 2); v) measuring the second phase shift level (D 2) between the at least two electrical quantities of the motor along a second stability stage (E 2), after the inflection stage (E inf) of the first phase shift level (D 1); and vi) de-energizing the start winding when the operating rotation (R 1) reaches the regime rotation (R 2).
Process for the preparation of L-methionine, comprising at least the steps of: a) preparation of a mixture comprising: 1) dimethyl disulfide (DMDS), 2) a catalytic amount of an amino acid carrying a thiol group or of a peptide comprising a thiol group, 3) a catalytic amount of an enzyme which catalyzes the reaction for the reduction of the disulfide bridge of the said amino acid carrying a thiol group or of the said peptide comprising a thiol group, 4) hydrogen, 5) a catalytic amount of an enzyme which catalyzes the reaction for the reduction of hydrogen, 6) a catalytic amount of a cofactor common to the two enzymes of the catalytic system (dehydrogenase and reductase), b) carrying out the enzymatic reaction in order to form methyl mercaptan (CH 3 -SH), c) addition of a precursor of the L-methionine and conversion of the said precursor with the methyl mercaptan formed in step b), and d) recovery and optionally purification of the L-methionine formed. a) preparation of a mixture comprising: 1) dimethyl disulfide (DMDS), 2) a catalytic amount of an amino acid carrying a thiol group or of a peptide comprising a thiol group, 3) a catalytic amount of an enzyme which catalyzes the reaction for the reduction of the disulfide bridge of the said amino acid carrying a thiol group or of the said peptide comprising a thiol group, 4) hydrogen, 5) a catalytic amount of an enzyme which catalyzes the reaction for the reduction of hydrogen, 6) a catalytic amount of a cofactor common to the two enzymes of the catalytic system (dehydrogenase and reductase), 1) dimethyl disulfide (DMDS), 2) a catalytic amount of an amino acid carrying a thiol group or of a peptide comprising a thiol group, 3) a catalytic amount of an enzyme which catalyzes the reaction for the reduction of the disulfide bridge of the said amino acid carrying a thiol group or of the said peptide comprising a thiol group, 4) hydrogen, 5) a catalytic amount of an enzyme which catalyzes the reaction for the reduction of hydrogen, 6) a catalytic amount of a cofactor common to the two enzymes of the catalytic system (dehydrogenase and reductase), b) carrying out the enzymatic reaction in order to form methyl mercaptan (CH 3 -SH), c) addition of a precursor of the L-methionine and conversion of the said precursor with the methyl mercaptan formed in step b), and d) recovery and optionally purification of the L-methionine formed.
A method of making a recycled plastic material, the method comprising the steps of: (a) providing a recycled medical waste material, a blending agent and one or more recycled plastic materials; (b) sterilizing the recycled medical waste material; (c) shredding and blending the product of step (b); (d) adding a blending agent and the one or more recycled plastic materials to the product of step (c); (e) blending the product of step (d); and (f) optionally pelletizing or grinding the product of step (e) and optionally further comprising: (g) forming a melt from the product of step (e) or step (f); and (h) extruding the melt to form a plastic product selected from the group consisting of a lumber, landscaping timbers, railroad ties, decking material, plastic-containing furniture, playground structures, building framing materials, structural members, roofing, and flooring, wherein the surface of the product is paintable. (a) providing a recycled medical waste material, a blending agent and one or more recycled plastic materials; (b) sterilizing the recycled medical waste material; (c) shredding and blending the product of step (b); (d) adding a blending agent and the one or more recycled plastic materials to the product of step (c); (e) blending the product of step (d); and (f) optionally pelletizing or grinding the product of step (e) (g) forming a melt from the product of step (e) or step (f); and (h) extruding the melt to form a plastic product selected from the group consisting of a lumber, landscaping timbers, railroad ties, decking material, plastic-containing furniture, playground structures, building framing materials, structural members, roofing, and flooring, wherein the surface of the product is paintable.
A method for manufacturing an optical fiber comprising: heating an optical fiber preform to draw glass fiber; measuring an outer diameter of the glass fiber to obtain a function of time; transforming the function of time into a function of frequency; identifying a first peak caused by a first drawing condition and a second peak caused by a second drawing condition in the function of frequency; adjusting the second drawing condition so as to satisfy fn < fm - wm / 2 or fn > fm + wm / 2, where fm is a frequency of the first peak, wm is a full width at half maximum of the first peak, and fn is a frequency of the second peak; forming a coating layer on the glass fiber to form an optical fiber; and twisting the optical fiber using a swing guide roller; wherein the second drawing condition is a swing frequency of the swing guide roller; wherein the first drawing condition is a characteristic vibration frequency of a manufacturing device. heating an optical fiber preform to draw glass fiber; measuring an outer diameter of the glass fiber to obtain a function of time; transforming the function of time into a function of frequency; identifying a first peak caused by a first drawing condition and a second peak caused by a second drawing condition in the function of frequency; adjusting the second drawing condition so as to satisfy fn < fm - wm / 2 or fn > fm + wm / 2, where fm is a frequency of the first peak, wm is a full width at half maximum of the first peak, and fn is a frequency of the second peak; forming a coating layer on the glass fiber to form an optical fiber; and twisting the optical fiber using a swing guide roller; wherein the second drawing condition is a swing frequency of the swing guide roller; wherein the first drawing condition is a characteristic vibration frequency of a manufacturing device.
A spheroidal graphite cast iron comprising: C: 3.3 to 4.0 mass%, Si: 2.1 to 2.4 mass%, Mn: 0.20 to 0.50 mass%, S: 0.005 to 0.030 mass%, Cu: 0.20 to 0.50 mass%, Mg: 0.03 to 0.06 mass% and the balance: Fe and inevitable impurities, wherein the total content of Mn and Cu is 0.45 to 0.60 mass% in total, a ratio of the content of Si by mass% and the total contents of Mn and Cu by mass% (Si/(Mn+Cu)) is 4.0 to 5.5, wherein the content of P does not exceed 0.05 % and the content of Cr does not exceed 0.1 %, wherein a tensile strength is 550 MPa or more, and an elongation is 12% or more, as determined in accordance with JIS Z 2241, a graphite nodule count is 300/mm 2 or more, and an average grain size of graphite is 20 μm or less, an impact value at normal temperature and -30°C is 10 J/cm 2 or more, wherein for impact value and percentage brittle fracture an impact specimen with U-notches produced in accordance with JIS Z 2241 is subjected to an impact test using a Charpy impact tester 50J to measure the impact value, a percentage brittle fracture of an impact fracture surface at 0°C is 50% or less, and wherein the perlite ratio (area of perlite)/(areas of perlite+ferrite) is 30 to 55%, wherein the graphite nodule count and the average grain size of graphite are determined by taking an observation site as an image by an optical microscope of 100 magnifications, binarizing the image by an image analysis system, measuring a number and an average grain size of parts darker than a matrix, which correspond to graphite, the measurement result being an average value of five observation sites, the graphite to be measured having the average grain size of 10 μm or more, the average grain size being an equivalent circle diameter.